Login / Signup

Self-Immolative Domino Dendrimers as Anticancer-Drug Delivery Systems: A Review.

Karolina KędraEwa OlędzkaMarcin Sobczak
Published in: Pharmaceutics (2024)
Worldwide cancer statistics have indicated about 20 million new cancer cases and over 10 million deaths in 2022 (according to data from the International Agency for Research on Cancer). One of the leading cancer treatment strategies is chemotherapy, using innovative drug delivery systems (DDSs). Self-immolative domino dendrimers (SIDendr) for triggered anti-cancer drugs appear to be a promising type of DDSs. The present review provides an up-to-date survey on the contemporary advancements in the field of SIDendr-based anti-cancer drug delivery systems (SIDendr-ac-DDSs) through an exhaustive analysis of the discovery and application of these materials in improving the pharmacological effectiveness of both novel and old drugs. In addition, this article discusses the designing, chemical structure, and targeting techniques, as well as the properties, of several SIDendr-based DDSs. Approaches for this type of targeted DDSs for anti-cancer drug release under a range of stimuli are also explored.
Keyphrases
  • papillary thyroid
  • squamous cell
  • drug release
  • randomized controlled trial
  • systematic review
  • lymph node metastasis
  • drug delivery
  • childhood cancer
  • high throughput
  • electronic health record